Close Menu

The Broad Institute is "biology, super-sized," says the Boston Globe's Carolyn Johnson in her profile of the institute. The center's approach to learning about disease is a example of how to use DNA sequencing to "change science and medicine," she adds. The Broad was founded in 2003 with the ultimate goal of abolishing diseases like diabetes, cancer, and even schizophrenia.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.